RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.

Glucocorticoids have deleterious effects on glucose and protein metabolism. RU 486 is an antiprogestin with antiglucocorticoid activity, which could be used to prevent the undesirable metabolic effects of glucocorticoids. A randomized, controlled, double blind study was performed in eight healthy male volunteers who were tested four times: during the iv infusion of cortisol (2 micrograms/kg.min for 5 h) after the oral ingestion of RU 486 (600 mg) or a placebo, and during the infusion of a normal saline solution with placebo or RU 486 ingestion. During each test, a primed continuous iv infusion of D-[6,6-2H]glucose and [1-13C-]leucine was given for the calculation of hepatic glucose production and plasma leucine appearance rate. 13CO2 enrichment in breath was measured for the calculation of leucine oxidation. Plasma concentrations of cortisol, ACTH, insulin, C-peptide, glucagon, and GH were measured at regular intervals. Compared to saline, cortisol infusion increased plasma glucose 5.5 +/- 0.6 vs. 4.7 +/- 0.4 mmol/L; P < 0.01) and leucine (179 +/- 35 vs. 155 +/- 35 mumol/L; P < 0.01) concentrations as well as the leucine appearance rate (2.24 +/- 0.3 vs. 2.0 +/- 0.28 mumol/kg.min; P < 0.05) and oxidation (0.51 +/- 0.22 vs. 0.39 +/- 0.06 mumol/kg.min; P < 0.01), and there was no change in hepatic glucose production. None of the metabolic changes induced by cortisol were seen when cortisol was administered after the ingestion of RU 486. When RU 486 was given before normal saline infusion, plasma glucose concentrations were transiently lower than those after placebo ingestion, as was the hepatic glucose production. No change in insulin, C-peptide, or glucagon was seen between tests. GH concentrations were higher during cortisol infusion, but not when cortisol was administered after the ingestion of RU 486. The following conclusions were reached. 1) RU 486 can suppress the effects of acute hypercortisolemia on glucose and protein metabolism and GH secretion in man. Long term studies are warranted to explore the potential of antiglucocorticoid molecules as preventive agents of the deleterious effects of chronic glucocorticoid administration. 2) RU 486 is useful molecule for studying the metabolic effects of cortisol in man.

[1]  R. Rizza,et al.  Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. , 1993, The Journal of clinical investigation.

[2]  L. de Jonge,et al.  Thermogenic response to food: intra-individual variability and measurement reliability. , 1993, Journal of the American College of Nutrition.

[3]  A. Atkinson,et al.  Influence of growth hormone on glucose-glucose 6-phosphate cycle and insulin action in normal humans. , 1992, The American journal of physiology.

[4]  P. Björntorp,et al.  The effects of cortisol on insulin sensitivity in muscle. , 1992, Acta physiologica Scandinavica.

[5]  B. Burguera,et al.  Corticosteroids as a New Stimulus of Growth Hormone Secretion in Man , 1992 .

[6]  F. Casanueva,et al.  Corticosteroid‐induced growth hormone secretion in normal and obese subjects , 1991, Clinical endocrinology.

[7]  D. Wagner,et al.  Prolonged fasting as conditioned by prior protein depletion: effect on urinary nitrogen excretion and whole-body protein turnover. , 1990, Metabolism: clinical and experimental.

[8]  F. Horber,et al.  Human growth hormone prevents the protein catabolic side effects of prednisone in humans. , 1990, The Journal of clinical investigation.

[9]  F. Horber,et al.  Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. , 1989, The American journal of physiology.

[10]  P. Delmas,et al.  Effects of moderate physical training on prednisone-induced protein wasting: a study of whole-body and bone protein metabolism. , 1988, Metabolism: clinical and experimental.

[11]  F. Horber,et al.  Thigh muscle mass and function in patients treated with glucocorticoids , 1985, European journal of clinical investigation.

[12]  G. Chrousos,et al.  Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. , 1985, The Journal of clinical endocrinology and metabolism.

[13]  F. Horber,et al.  Evidence that prednisone-induced myopathy is reversed by physical training. , 1985, The Journal of clinical endocrinology and metabolism.

[14]  M. Haymond,et al.  Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range. , 1984, The Journal of clinical investigation.

[15]  W. Rand,et al.  Underestimation of metabolic rates owing to reincorporation of 14CO2 in the perfused rat liver. , 1982, The Biochemical journal.

[16]  L. Mandarino,et al.  Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.

[17]  R. Sherwin,et al.  The influence of acute physiological increments of cortisol on fuel metabolism and insulin binding to monocytes in normal humans. , 1980, The Journal of clinical endocrinology and metabolism.

[18]  A. Munck.  Glucocorticoid Inhibition of Glucose Uptake by Peripheral Tissues: Old and New Evidence, Molecular Mechanisms, and Physiological Significance , 2015, Perspectives in biology and medicine.

[19]  F. H. Tyler,et al.  EARLY EFFECT OF CORTISOL ON GLUCOSE METABOLISM IN MAN. , 1963, The Journal of laboratory and clinical medicine.